Press Releases

Date Title and Summary
Toggle Summary Emerging Clinical Data Continues to Support CyberKnife Radiosurgery for the Treatment of Lung Cancer
Physician Usage and Patient Demand Grow Dramatically SUNNYVALE, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that emerging clinical data continues to support CyberKnife radiosurgery for the treatment of
Toggle Summary Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
Click here for PDF version of this release 28 New Contracts Valued at $115.5 Million Signed in Fourth Quarter SUNNYVALE, Calif., Aug. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth
Toggle Summary West Coast Cancer Center Breaks Ground on New Building to House CyberKnife System
SUNNYVALE, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Comprehensive Blood and Cancer Center (CBCC) -- one of the nation's largest freestanding, physician owned and operated comprehensive
Toggle Summary Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
SUNNYVALE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, will host an Investor and Analyst Meeting in Boston, Mass. on Tuesday, September 23, 2008 at 2:00 p.m. EDT (11:00 a.m. PDT).
Toggle Summary Accuray Incorporated Announces Resignation of Chief Financial Officer
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Robert E. McNamara has resigned as chief financial officer and senior vice president to pursue other interests.
Toggle Summary Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference
SUNNYVALE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the UBS Global Life Sciences Conference in New
Toggle Summary Accuray Incorporated and IMPAC Medical Systems to Link CyberKnife(R) Robotic Radiosurgery System with MOSAIQ(R) EMR
Partnership underscores widespread adoption of the CyberKnife System and IMPAC's commitment to vendor independent connectivity SUNNYVALE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY) and IMPAC Medical Systems, Inc. announced today that they will collaborate to
Toggle Summary Accuray Launches New Configuration for CyberKnife System to Offer Hospitals Installation Flexibility
New Footprint Enables Hospitals to Save Construction Costs and Speed Deployment Time by Placing CyberKnife System in Existing Vault SUNNYVALE, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it is
Toggle Summary Accuray Licenses Technology From Morphormics for Prostate Cancer Treatment Planning
Investment Confirms Company's Commitment to Improving Ability to Treat Prostate SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company is partnering with Morphormics Incorporated, a
Toggle Summary Accuray Introduces the InTempo(TM) Adaptive Imaging System to Address Prostate Motion That Commonly Occurs During Radiation Treatment Delivery
New Capabilities Help to Ensure Prescribed Dose is Delivered to the Prostate While Precisely Controlling Exposure to Surrounding Healthy Tissue SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today introduced

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.